Table 1

Baseline characteristics

MBCT (n = 31)CBT (n = 32)Waiting list (n = 31)Total (n = 94)*
Age (years), mean (SD)49.8 (13.3)54.6 (11.3)54.7 (10.5)53.1 (11.8)
Sex, n (%)
 Male17 (55)16 (50)15 (48)48 (51)
 Female14 (45)16 (50)16 (52)46 (49)
Education, n (%)
 Lower level vocational school8 (26)10 (31)5 (16)23 (25)
 Secondary education/advanced level vocational school14 (45)15 (47)18 (58)47 (50)
 Higher or university education9 (29)7 (22)8 (26)24 (25)
Employment, n (%)
 Employed16 (52)15 (47)21 (68)52 (55)
 Not employed15 (48)17 (53)10 (32)42 (45)
Relationship status, n (%)
 In a relationship24 (77)22 (69)21 (68)67 (71)
 Not in a relationship7 (23)10 (31)10 (32)27 (29)
BMI, mean (SD)29.3 (7.6)31.9 (6.6)30.6 (8.4)30.6 (7.6)
Type of diabetes, n (%)
 Type 115 (48)11 (34)11 (36)37 (39)
 Type 216 (52)21 (66)20 (65)57 (61)
Diabetes treatment, n (%)
 Oral medication4 (13)4 (12)4 (13)12 (13)
 Oral medication and insulin10 (32)14 (44)11 (36)35 (37)
 Insulin17 (55)14 (44)16 (51)47 (50)
Time since diagnosis (years), mean (SD)17.8 (13.0)15.0 (11.4)17.0 (11.4)16.6 (11.9)
Diabetes complications, n (%)
 One or more complications9 (29)13 (40)9 (29)31 (33)
 No complications22 (71)19 (60)22 (71)63 (77)
Comorbidity, n (%)
 One or more comorbidities14 (45)18 (56)18 (58)50 (53)
 No comorbidity17 (55)14 (44)13 (42)44 (47)
Antidepressant use at trial entry, n (%)
 Usage2 (7)5 (16)3 (10)10 (11)
 No usage29 (93)27 (84)28 (90)84 (89)
  • *Groups did not significantly differ (P > 0.05 in all cases) on any of the demographics and clinical characteristics.

  • †Included diabetes complications are: retinopathy, neuropathy, nephropathy, and diabetic foot.